Key result
Rising natriuretic peptides track closely with imminent heart failure hospitalization in post-ACS diabetes.
Why the study?
Limited data exist on the temporal changes in natriuretic peptides preceding heart failure hospitalization in patients with recent coronary events and type 2 diabetes mellitus.
Do increases in natriuretic peptides precede heart failure hospitalization in patients with a recent coronary event and type 2 diabetes mellitus?
RCT (n=5,450)
randomized
Yes
Do increases in natriuretic peptides precede heart failure hospitalization in patients with a recent coronary event and type 2 diabetes mellitus?
In patients with type 2 diabetes and a recent acute coronary syndrome, increases in natriuretic peptides precede heart failure hospitalization, highlighting their potential utility for identifying patients at imminent risk.
Answers are grounded in this paper and cite their sources.
May aid imminent HFH risk identification after coronary events; leaves open whether serial natriuretic peptide monitoring improves outcomes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Wolsk et al. (2017) conducted an RCT in Recent coronary event and type 2 diabetes mellitus (n=5,450). Lixisenatide was evaluated on Hospitalization for heart failure (HFH). Natriuretic peptide concentrations were significantly greater when measured closer to the time of heart failure hospitalization, which occurred in 3% of patients with type 2 diabetes and recent ACS.
Synapse has enriched 10 related papers. Consider them for comparative context: